A stern warning and gloomy forecast were delivered to the pharmaceutical industry at the Drug Discovery and Technology Summit in London this week.
Declining drug pipelines and expiring patents were a recurring concern. In his speech at the event, Simon Campbell, former president of the Royal Society of Chemistry, was scathing about the relentless 'march of mega-pharma'.
Campbell was at Pfizer for 26 years before retiring, in 1998, as senior vice president for worldwide discovery and for medicinals research and development in Europe.
He cited the increasing number of mergers and continual expansion of the huge multi-national drug giants as one cause of the industry's plight.
Consolidation, he said, was having a negative impact on the actual process of research and development.
Innovation does not scale.
'You can't industrialise drug discovery,' said Campbell. 'It's a personal experience, not a mechanical process, and that needs to be appreciated.'
More
Insider's view: hope you get todays theme......
Hat tips: eDrugSearch and On Pharma
No comments:
Post a Comment